2-[bis[(2,4-Difluoro-3-hydroxy-phenyl)methyl]amino]-ethanehydroxamic Acid

ID: ALA4209993

Chembl Id: CHEMBL4209993

PubChem CID: 132051489

Max Phase: Preclinical

Molecular Formula: C16H14F4N2O4

Molecular Weight: 374.29

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  O=C(CN(Cc1ccc(F)c(O)c1F)Cc1ccc(F)c(O)c1F)NO

Standard InChI:  InChI=1S/C16H14F4N2O4/c17-10-3-1-8(13(19)15(10)24)5-22(7-12(23)21-26)6-9-2-4-11(18)16(25)14(9)20/h1-4,24-26H,5-7H2,(H,21,23)

Standard InChI Key:  QXUDREYOXKXYRI-UHFFFAOYSA-N

Alternative Forms

1. Parent:

   

   ALA4209993

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 374.29

Molecular Weight (Monoisotopic): 374.0890

AlogP: 2.16

#Rotatable Bonds: 6

Polar Surface Area: 93.03

Molecular Species: NEUTRAL

HBA: 5

HBD: 4

#RO5 Violations: ┄

HBA (Lipinski): 6

HBD (Lipinski): 4

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 7.14

CX Basic pKa: 3.26

CX LogP: 2.27

CX LogD: 1.71

Aromatic Rings: 2

Heavy Atoms: 26

QED Weighted: 0.35

Np Likeness Score: -0.73

References

1. Ramsbeck D, Hamann A, Richter G, Schlenzig D, Geissler S, Nykiel V, Cynis H, Schilling S, Buchholz M..  (2018)  Structure-Guided Design, Synthesis, and Characterization of Next-Generation Meprin β Inhibitors.,  61  (10): [PMID:29694039] [10.1021/acs.jmedchem.8b00330]

Source

Source(1):

• Scientific Literature